Global Malaria Programme
The WHO Global Malaria Programme (GMP) is responsible for coordinating WHO's global efforts to control and eliminate malaria. Its work is guided by the "Global technical strategy for malaria 2016–2030" adopted by the World Health Assembly in May 2015.
 

Publications

All →
20 years of global progress & challenges
WHO Guidelines for malaria

The WHO Guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate...

Fourteenth meeting of the WHO Vector Control Advisory Group

VCAG experts met virtually with product developers, innovators and researchers from 19 to 21 April 2021 for the 14th VCAG meeting. This report details...

WHO Malaria Policy Advisory Group (‎MPAG)‎ meeting (April 2021)

On 13–15 April 2021, the WHO Malaria Policy Advisory Group (MPAG) convened virtually to review updates and progress, and to provide guidance on thematic...

Guidance framework for testing of genetically modified mosquitoes, second edition

For more than 2 decades, scientists have been working to harness the promise of molecular biology to develop genetically modified mosquitoes (GMMs) for...

Global technical strategy for malaria 2016-2030, 2021 update
A framework to guide countries in their efforts to accelerate progress towards malaria elimination.

Other documents

All →
WHO-UCN-GMP-2020

This brochure complements the Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). It includes...

During the COVID-19 pandemic, the malaria community must remain committed to supporting the prevention of malaria infection, illness and death through...

Tracking biological threats to malaria control and elimination

The WHO Malaria Threats Map is an interactive data visualization platform that presents the latest status of the 4 major biological threats to malaria control and elimination: insecticide resistance in malaria vectors; P. falciparum hrp2/3 gene deletions; antimalarial drug efficacy and resistance; and invasive malaria vector species.

 

Advisory bodies

Guideline development process

 

Malaria and COVID-19

Contact us